42 articles for RH Mach
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands fora-Synuclein Fibrils.

Washington University
Synthesis and evaluation of tetrahydroindazole derivatives as sigma-2 receptor ligands.

Guangdong Medical College
Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D3 receptor ligands.

Washington University
Synthesis and structure-activity relationship studies of conformationally flexible tetrahydroisoquinolinyl triazole carboxamide and triazole substituted benzamide analogues ass2 receptor ligands.

Washington University
Thes2 receptor: a novel protein for the imaging and treatment of cancer.

Washington University
Synthesis, [¹8F] radiolabeling, and evaluation of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors for in vivo imaging of PARP-1 using positron emission tomography.

Washington University Saint Louis
Evaluation of N-phenyl homopiperazine analogs as potential dopamine D3 receptor selective ligands.

Washington University
Synthesis, radiolabeling and initial in vivo evaluation of [(11)C]KSM-01 for imaging PPAR-a receptors.

Washington University
Exploration of ring size in a series of cyclic vicinal diamines withs1 receptor affinity.

The University of Sydney
Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626.

Washington University
Synthesis and in vitro biological evaluation of carbonyl group-containing inhibitors of vesicular acetylcholine transporter.

University of Minnesota
18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography.

University of Pennsylvania
Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.

University of Pennsylvania
N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.

The University of Sydney
Synthesis and in vitro evaluation of new analogues as inhibitors for phosphodiesterase 10A.

Washington University
Synthesis and characterization of selective dopamine D2 receptor ligands using aripiprazole as the lead compound.

Washington University
Synthesis and evaluation of isatin analogs as caspase-3 inhibitors: introduction of a hydrophilic group increases potency in a whole cell assay.

Washington University
Synthesis and pharmacological evaluation of fluorine-containing D3 dopamine receptor ligands.

Washington University
Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter.

Washington University
Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [18F]6-(2-fluoropropyl)-4-methyl-pyridin-2-amine as a potential PET tracer for inducible nitric oxide synthase.

Washington University
New N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs as sigma2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents.

Washington University
Synthesis of bitopic ligands based on fallypride and evaluation of their affinity and selectivity towards dopamine D2 and D3 receptors.

University of Pennsylvania
Isatin sulfonamide analogs containing a Michael addition acceptor: a new class of caspase 3/7 inhibitors.

Washington University
Fluorine-18-labeled benzamide analogues for imaging the sigma2 receptor status of solid tumors with positron emission tomography.

Washington University
Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis.

Washington University
Conformationally-flexible benzamide analogues as dopamine D3 and sigma 2 receptor ligands.

Wake Forest University School of Medicine
Synthesis, binding, and functional properties of tetrahydroisoquinolino-2-alkyl phenones as selective σ

Guangdong Medical University
Synthesis and structure-activity relationships of N-(1-benzylpiperidin-4-yl)arylacetamide analogues as potent sigma1 receptor ligands.

Wake Forest University School of Medicine
Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands.

Wake Forest University School of Medicine
Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D

University of Pennsylvania
Hydroxylated decahydroquinolines as ligands for the vesicular acetylcholine transporter: synthesis and biological evaluation.

University of Minnesota
Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl)butyl)-4-(thiophen-3-yl)benzamides as selective dopamine D

Temple University
Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.

Wake Forest University School of Medicine
N-hydroxyalkyl derivatives of 3 beta-phenyltropane and 1-methylspiro[1H-indoline-3,4'-piperidine]: vesamicol analogues with affinity for monoamine transporters.

University of Minnesota
Synthesis and

Washington University School of Medicine
Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands.

Guangdong Medical University
Examination of Diazaspiro Cores as Piperazine Bioisosteres in the Olaparib Framework Shows Reduced DNA Damage and Cytotoxicity.

University of Pennsylvania
Highly Selective Dopamine D

University of Pennsylvania
Effect of N-alkylation on the affinities of analogues of spiperone for dopamine D2 and serotonin 5-HT2 receptors.

University of Pennsylvania
Substituted pyrrolizine compounds and uses thereof

Gilead Sciences
Organic compounds

Intra-Cellular Therapies
4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors.

Dupont Pharmaceuticals